Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Model of Belimumab Response in SLE
NCT04893161Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jun 2024
- Primary completion
- Jan 2026
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 4 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04893161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04893161.